US Patent 9345702 Methods of treatment using selective Bcl-2 inhibitors
Patent 9345702 was granted and assigned to AbbVie Inc. on May, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 17 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+434 characters)
Article
Patent abstract
This invention pertains to methods of treating systemic lupus erythematosus and Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl-2 anti-apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl-xL.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09345702 Methods of treatment using selective Bcl-2 inhibitors US Patent 9345702 Methods of treatment using selective Bcl-2 inhibitors
Infobox
Patent Number
0934570200
Patent Number
934570200
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093457020
Date of Patent
May 24, 2016
0Patent Application Number
145350700
Date Filed
November 6, 2014
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093457020
Date of Patent
May 24, 2016
0Patent Application Number
145350700
Date Filed
November 6, 2014
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09345702 Methods of treatment using selective Bcl-2 inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09345702
Date of patent
May 24, 2016
Patent application number
14535070
Date Filed
November 6, 2014
Patent primary examiner
Find more entities like US Patent 9345702 Methods of treatment using selective Bcl-2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
